This page includes the latest FDA filings for Acorda Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ACOR | DUNS 963845136 |
| Registration Number | 3002457563 |
| FEI Number | 3002457563 |
| Name | ACORDA THERAPEUTICS, INC. |
| Owner & Operator | Acorda Therapeutics, Inc. |
| Contact Address | 420 Saw Mill River Rd. Ardsley NY 10502 US |
| Official Correspondent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | 420 Saw Mill River Rd. Ardsley, NY 10502 US |
| Establishment Type | Repack or Relabel Medical Device |
Device Company | Device | Date |
|---|---|---|
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2024-07-13 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2024-07-13 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2024-03-15 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2023-01-24 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2023-01-21 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2022-12-21 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2022-12-21 |
| Acorda Therapeutics, Inc. | INBRIJA® | 2022-12-06 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2022-02-16 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2021-12-01 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2021-03-07 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2021-01-06 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2020-09-12 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2019-12-21 |
ACORDA THERAPEUTICS, INC. | INBRIJA | 2019-10-09 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2019-09-24 |
| Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH, Avista Pharma Solutions, Inc., Boston Analytical, Inc., Catalent Massachusetts LLC, Sharp Corporation, Ajinomoto Company, Inc., PPD Development Ireland Ltd. | Prescription Medication | 2019-09-10 |
| Acorda Therapeutics, Inc. | Inbrija | 2018-12-22 |
| Acorda Therapeutics, Inc., Sharp Corporation, Contract Pharmaceuticals Limited Canada - Lab Svcs (CPL), SGS Life Science Services, Exova Canada Inc., Contract Pharmaceuticals Limited Canada (CPL), SGS Institut Fresenius GmbH, Lohmann Therapie-Systeme AG (LTS) (Ge | Prescription Medication | 2018-11-06 |
| Acorda Therapeutics, Inc., ALKERMES GAINESVILLE LLC, Sharp Corporation, PATHEON INC., ALKERMES PHARMA IRELAND LIMTED | Prescription Medication | 2018-10-20 |
| Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2017-10-12 |
| Acorda Therapeutics, Inc. | Qutenza | 2013-08-12 |
| Acorda Therapeutics, Inc. | Qutenza | 2013-08-12 |
| Acorda Therapeutics, Inc. | AMPYRA | 2010-03-01 |
| Acorda Therapeutics, Inc. | Zanaflex | 2005-04-04 |
| Acorda Therapeutics, Inc. | Zanaflex | 2005-04-04 |
| Acorda Therapeutics, Inc. | Zanaflex | 2005-04-04 |
| Acorda Therapeutics, Inc. | Zanaflex | 1997-01-01 |
| NCAGE Code | 305Q1 | ACORDA THERAPEUTICS, INC. |
| CAGE Code | 305Q1 | ACORDA THERAPEUTICS, INC. |
| S.A.M. Registration | 305Q1 [963845136] | ACORDA THERAPEUTICS, INC. |
| SEC | 0001008848 | ACORDA THERAPEUTICS INC |
| Import ID | Shipment | Cargo Description | Quantity |
|---|---|---|---|
| 2018062688987 | Rotterdam,Netherlands -> New York/Newark Area, Newark, New Jersey | USED OFFICE FURNITURE AND ACCESSORIES | 158 PKG |
| 2018062688988 | Rotterdam,Netherlands -> New York/Newark Area, Newark, New Jersey | USED OFFICE FURNITURE AND ACCESSORIES | 158 PKG |